Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
61.44
-3.22 (-4.98%)
At close: Dec 5, 2025, 4:00 PM EST
62.20
+0.76 (1.24%)
After-hours: Dec 5, 2025, 7:29 PM EST

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2020 - 2016
Market Capitalization
8,3444,7692,4082,8803,4986,509
Upgrade
Market Cap Growth
252.89%98.03%-16.40%-17.67%-46.25%47.77%
Upgrade
Enterprise Value
8,1604,5812,4362,7993,1836,017
Upgrade
Last Close Price
61.4434.4919.3726.8733.0562.43
Upgrade
PS Ratio
9.915.75678.1211.9614.3847.07
Upgrade
PB Ratio
17.899.4712.6010.038.3615.92
Upgrade
P/TBV Ratio
18.1710.3913.6111.039.0516.47
Upgrade
P/FCF Ratio
53.1930.40---44.06
Upgrade
P/OCF Ratio
46.4726.56---37.99
Upgrade
EV/Sales Ratio
9.845.52686.0211.6313.0943.51
Upgrade
EV/EBITDA Ratio
66.7437.47----
Upgrade
EV/EBIT Ratio
82.9846.58----
Upgrade
EV/FCF Ratio
52.0129.20---40.72
Upgrade
Debt / Equity Ratio
1.461.464.461.340.200.06
Upgrade
Debt / EBITDA Ratio
5.295.29----
Upgrade
Debt / FCF Ratio
4.684.68---0.17
Upgrade
Asset Turnover
0.660.660.000.330.350.22
Upgrade
Quick Ratio
4.734.736.573.752.672.58
Upgrade
Current Ratio
4.864.866.743.952.922.63
Upgrade
Return on Equity (ROE)
8.67%8.67%-254.98%-59.33%-42.68%-32.36%
Upgrade
Return on Assets (ROA)
4.87%4.87%-39.43%-17.58%-15.91%-15.11%
Upgrade
Return on Capital (ROIC)
5.39%5.39%-43.84%-21.89%-23.88%-20.31%
Upgrade
Return on Capital Employed (ROCE)
8.30%8.30%-58.00%-31.10%-32.30%-26.40%
Upgrade
Earnings Yield
-0.02%-0.03%-24.90%-7.13%-5.03%-2.16%
Upgrade
FCF Yield
1.88%3.29%-25.10%-11.48%-5.40%2.27%
Upgrade
Buyback Yield / Dilution
-11.67%-11.67%-12.21%-1.26%-1.62%-3.00%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.